BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26166407)

  • 1. Preparation of starch macrocellular foam for increasing the dissolution rate of poorly water-soluble drugs.
    Zhao Y; Wu C; Zhao Z; Hao Y; Xu J; Yu T; Qiu Y; Jiang J
    Pharm Dev Technol; 2016 Sep; 21(6):749-54. PubMed ID: 26166407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of a Mesoporous Structure of SnO
    Liu X; Wu C; Bai A; Lv H; Xu X; Cao Y; Shang W; Hu L; Liu Y
    AAPS PharmSciTech; 2018 Oct; 19(7):3228-3236. PubMed ID: 30187447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs.
    Wu C; Wang Z; Zhi Z; Jiang T; Zhang J; Wang S
    Int J Pharm; 2011 Jan; 403(1-2):162-9. PubMed ID: 20937370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of a novel starch-derived three-dimensional ordered macroporous carbon for improving the dissolution rate and oral bioavailability of water-insoluble drugs.
    Liu Y; Wu C; Hao Y; Xu J; Zhao Y; Qiu Y; Jiang J; Yu T; Ji P
    J Pharm Biomed Anal; 2016 Jan; 118():267-275. PubMed ID: 26580824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of novel porous starch microsphere foam for loading and release of poorly water soluble drug.
    Jiang T; Wu C; Gao Y; Zhu W; Wan L; Wang Z; Wang S
    Drug Dev Ind Pharm; 2014 Feb; 40(2):252-9. PubMed ID: 23391363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable Porous Starch Spheres as a Novel Carrier for Enhancement of Dissolution Rate and Oral Bioavailability of Itraconazole.
    Pawar J; Ali MT; Fule R; Moravkar K; Seervi M; Sathaye S; Amin P
    Curr Drug Deliv; 2017; 14(7):944-954. PubMed ID: 27654575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing the dissolution rate and oral bioavailability of the poorly water-soluble drug valsartan using novel hierarchical porous carbon monoliths.
    Zhang Y; Che E; Zhang M; Sun B; Gao J; Han J; Song Y
    Int J Pharm; 2014 Oct; 473(1-2):375-83. PubMed ID: 25051114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel starch with a three-dimensional ordered macroporous structure for improving the dissolution rate of felodipine.
    Hao Y; Wu C; Zhao Z; Zhao Y; Xu J; Qiu Y; Jiang J; Yu T; Ma C; Zhou B
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():1131-7. PubMed ID: 26478413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in rats.
    Xia D; Cui F; Piao H; Cun D; Piao H; Jiang Y; Ouyang M; Quan P
    Pharm Res; 2010 Sep; 27(9):1965-76. PubMed ID: 20585842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
    Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
    Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs.
    Wu C; Sun X; Zhao Z; Zhao Y; Hao Y; Liu Y; Gao Y
    Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():262-7. PubMed ID: 25280705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.
    Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J
    Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
    Zhang Y; Zhi Z; Li X; Gao J; Song Y
    Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D; Sailaja Chirravuri SV; Shastri NR
    Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug.
    Tran HT; Park JB; Hong KH; Choi HG; Han HK; Lee J; Oh KT; Lee BJ
    Int J Pharm; 2011 Aug; 415(1-2):83-8. PubMed ID: 21641985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of mesoporous carbon/lipid bilayer nanocomposites for improved oral delivery of the poorly water-soluble drug, nimodipine.
    Zhang Y; Zhao Q; Zhu W; Zhang L; Han J; Lin Q; Ai F
    Pharm Res; 2015 Jul; 32(7):2372-83. PubMed ID: 25609013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Nanonized Nitrendipine and Its Transformation into Nanoparticulate Oral Fast Dissolving Drug Delivery System.
    Gandhi NV; Deokate UA; Angadi SS
    AAPS PharmSciTech; 2021 Mar; 22(3):113. PubMed ID: 33751276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
    Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel pH-dependent gradient-release delivery system for nitrendipine: I. Manufacturing, evaluation in vitro and bioavailability in healthy dogs.
    Yang M; Cui F; You B; You J; Wang L; Zhang L; Kawashima Y
    J Control Release; 2004 Aug; 98(2):219-29. PubMed ID: 15262414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: improved solubility and reduced pharmacokinetic variability.
    Sangwai M; Vavia P
    Int J Pharm; 2013 Sep; 453(2):423-32. PubMed ID: 22935741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.